Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram
per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne
scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars
count.